Merck MRK, known as MSD outside the United States and Canada,
announced today that the Japanese Ministry of Health, Labour and Welfare approved three products - GARDASIL, ZOLINZA and
CUBICIN – for use in Japan.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in